Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GYRE | AZN | AMGN | GILD | VRTX |
| Company | Gyre Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 7.24 | 92.53 | 333.65 | 125.52 | 462.67 |
| High | 7.35 | 92.84 | 333.98 | 125.77 | 463.65 |
| Low | 7.18 | 92.18 | 331.25 | 124.55 | 461.01 |
| Latest | 7.30 | 92.62 | 331.25 | 124.49 | 461.74 |
| Change | +0.11 | +0.17 | -2.71 | -1.18 | -1.25 |
| % Change | +1.53% | +0.18% | -0.81% | -0.94% | -0.27% |
| Volume | 44,448 | 544,498 | 169,487 | 543,107 | 84,739 |
| 20-Day Average Volume | 89,172 | 5,332,104 | 3,001,504 | 6,867,456 | 1,360,315 |
| Previous Close | 7.19 | 92.45 | 333.96 | 125.67 | 462.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.63 | 91.03 | 329.03 | 122.69 | 449.89 |
| 20-Day Raw Stochastic | 26.71% | 86.39% | 56.26% | 67.71% | 92.70% |
| 20-Day Relative Strength | 45.30 | 60.60 | 55.42 | 54.43 | 60.97 |
| Weighted Alpha | -30.47 | +42.99 | +26.65 | +31.02 | +13.67 |
| Today's Opinion | 88% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 96% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 32% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.14% since 12/18/25 | +2.17% since 12/18/25 | +2.19% since 12/18/25 | +2.65% since 12/18/25 | +3.14% since 12/18/25 |
| Low | 6.92 on 12/19/25 | 90.36 on 12/19/25 | 324.73 on 12/19/25 | 121.00 on 12/19/25 | 445.51 on 12/19/25 |
| High | 7.39 on 12/22/25 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | -6.50% since 11/26/25 | -0.79% since 11/26/25 | -3.79% since 11/26/25 | -2.21% since 11/26/25 | +6.78% since 11/26/25 |
| Low | 6.92 on 12/19/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 8.50 on 12/10/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.80 on 11/28/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +2.51% since 09/26/25 | +25.52% since 09/26/25 | +21.44% since 09/26/25 | +11.23% since 09/26/25 | +19.63% since 09/26/25 |
| Low | 6.92 on 12/19/25 | 73.68 on 09/29/25 | 270.67 on 09/29/25 | 108.46 on 10/02/25 | 384.39 on 09/29/25 |
| High | 9.42 on 10/16/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | -0.54% since 06/26/25 | +32.13% since 06/26/25 | +18.77% since 06/26/25 | +15.86% since 06/26/25 | +4.07% since 06/26/25 |
| Low | 6.57 on 08/01/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 106.84 on 06/27/25 | 362.50 on 08/11/25 |
| High | 9.42 on 10/16/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 692,634 | 286,729,216 | 179,831,120 | 155,916,256 | 117,469,352 |
| Shares Outstanding, K | 96,333 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 105,760,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 12,090,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 30,560,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 3,610,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.96 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 11/07/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/16/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | 0.569 on 08/20/15 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 89.75 | 20.16 | 15.16 | 15.29 | 29.99 |